BRVE
Braveheart Bio, Inc.
21.30$
-0.7%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 25 | Q2 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|
| – | – | -0.07 | -0.23 | |
| – | – | 0.00 | 0.00 | |
| – | – | 0.02 | 0.01 | |
| – | – | 0.10 | -0.04 | |
| – | – | 0.04 | 0.00 | |
| – | – | 0.00 | 0.81 | |
| – | – | -0.12 | 0.58 | |
| – | – | -0.11 | -0.23 |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.